Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3389/fimmu.2020.574027 http://scihub22266oqcxt.onion/10.3389/fimmu.2020.574027 33101299!7546400!33101299     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Front+Immunol 2020 ; 11 (ä): 574027 Nephropedia Template TP {{tp|p=33101299|t=2020. Insights Into Type I and III Interferons in Asthma and Exacerbations |pdf=|usr=}}{{33101299}} gab.com Text Insights Into Type I and III Interferons in Asthma and Exacerbations JO: Front Immunol http://www.kidney.de/pget.php?&tw=1&pmid=33101299 #FOAvip Asthma is a highly prevalent, chronic respiratory disease that impacts millions of people worldwide and causes thousands of deaths every year. Asthmatics display different phenotypes with distinct genetic components, environmental causes, and immunopathologic signatures, and are broadly characterized into type 2-high or type 2-low (non-type 2) endotypes by linking clinical characteristics, steroid responsiveness, and molecular pathways. Regardless of asthma severity and adequate disease management, patients may experience acute exacerbations of symptoms and a loss of disease control, often triggered by respiratory infections. The interferon (IFN) family represents a group of cytokines that play a central role in the protection against and exacerbation of various infections and pathologies, including asthma. Type I and III IFNs in particular play an indispensable role in the host immune system to fight off pathogens, which seems to be altered in both pediatric and adult asthmatics. Impaired IFN production leaves asthmatics susceptible to infection and with uncontrolled type 2 immunity, promotes airway hyperresponsiveness (AHR), and inflammation which can lead to asthma exacerbations. However, IFN deficiency is not observed in all asthmatics, and alterations in IFN expression may be independent of type 2 immunity. In this review, we discuss the link between type I and III IFNs and asthma both in general and in specific contexts, including during viral infection, co-infection, and bacterial/fungal infection. We also highlight several studies which examine the potential role for type I and III IFNs as asthma-related therapies. Twit Text FOAVip Insights Into Type I and III Interferons in Asthma and Exacerbations ????Front Immunol http://www.kidney.de/pget.php?&tw=1&pmid=33101299 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33101299 #FOAvip English Wikipedia <ref>{{Cite pmid|33101299}}</ref> Insights Into Type I and III Interferons in Asthma and Exacerbations #MMPMID33101299 Rich HE; Antos D; Melton NR; Alcorn JF; Manni ML Front Immunol 2020[]; 11 (ä): 574027 PMID33101299show ga Asthma is a highly prevalent, chronic respiratory disease that impacts millions of people worldwide and causes thousands of deaths every year. Asthmatics display different phenotypes with distinct genetic components, environmental causes, and immunopathologic signatures, and are broadly characterized into type 2-high or type 2-low (non-type 2) endotypes by linking clinical characteristics, steroid responsiveness, and molecular pathways. Regardless of asthma severity and adequate disease management, patients may experience acute exacerbations of symptoms and a loss of disease control, often triggered by respiratory infections. The interferon (IFN) family represents a group of cytokines that play a central role in the protection against and exacerbation of various infections and pathologies, including asthma. Type I and III IFNs in particular play an indispensable role in the host immune system to fight off pathogens, which seems to be altered in both pediatric and adult asthmatics. Impaired IFN production leaves asthmatics susceptible to infection and with uncontrolled type 2 immunity, promotes airway hyperresponsiveness (AHR), and inflammation which can lead to asthma exacerbations. However, IFN deficiency is not observed in all asthmatics, and alterations in IFN expression may be independent of type 2 immunity. In this review, we discuss the link between type I and III IFNs and asthma both in general and in specific contexts, including during viral infection, co-infection, and bacterial/fungal infection. We also highlight several studies which examine the potential role for type I and III IFNs as asthma-related therapies. |Asthma/drug therapy/etiology/*immunology[MESH] |Bacteria/pathogenicity[MESH] |Fungi/pathogenicity[MESH] |Humans[MESH] |Immunomodulation[MESH] |Interferons/*immunology/*therapeutic use[MESH] |Lung/immunology[MESH] |Respiratory Tract Infections/complications/drug therapy/immunology[MESH] |T-Lymphocytes, Helper-Inducer/immunology[MESH]Insights Into Type I and III Interferons in Asthma and Exacerbations (epmc).pdf DeepDyve Pubget Overpricing